http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120032317-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0fc2b70675ee19bd5fc464f5ae9061 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 |
| filingDate | 2010-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b03734dbf94334ec55f99ec55b9b7f38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8da3c40f0c572568e76d96048e4e9d8b |
| publicationDate | 2012-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20120032317-A |
| titleOfInvention | SiRNA of the CCL22 Gene Having a Therapeutic Effect on Atopic Dermatitis and a Composition Containing the Same |
| abstract | The present invention relates to a small interfering RNA having a therapeutic effect on atopic dermatitis, more specifically, containing as an active ingredient a bacterial cell transformed with a recombinant vector expressing a small interfering RNA (siRNA) that suppresses the expression of the CCL22 gene It relates to a composition for treating atopic dermatitis. According to the present invention, a bacterial cell transformed with a recombinant vector expressing a small interfering RNA (siRNA) that suppresses the expression of the CCL22 gene can be prepared, and the bacterial cell can be used to suppress the induction of atopic dermatitis. . Therefore, the therapeutic composition using a small interference RNA (siRNA) having a therapeutic effect on atopic dermatitis can be very useful in the pharmaceutical industry as a treatment and prevention of atopic dermatitis, in which there is no appropriate therapeutic agent for refractory diseases. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9227956-B2 |
| priorityDate | 2010-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.